Orris

What is acid base status of ckd

Reading File
Finding Sources
Searching PubMed

metabolic acidosis chronic kidney disease

Reading File
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
I now have excellent, comprehensive textbook content from Harrison's 22E and Goldman-Cecil Medicine. Here is the full answer:

Acid-Base Status in Chronic Kidney Disease (CKD)

Primary Disturbance: Metabolic Acidosis

CKD causes metabolic acidosis as the kidney progressively loses its ability to excrete the net acid load (~1 mEq/kg/day) generated from protein metabolism and endogenous acid production.

Anion Gap Pattern by CKD Stage

This is the most important clinical concept - the type of metabolic acidosis evolves with disease progression:
CKD StageGFR (mL/min/1.73m²)Acid-Base PatternMechanism
Stage 3 (Mild-Moderate)30-59Normal Anion Gap (Hyperchloremic) Metabolic AcidosisReduced NH4+ production/excretion; HCO3- falls, Cl- rises reciprocally
Stage 3B-415-30Transitional / MixedBoth mechanisms contributing
Stage 4-5 (Advanced/ESRD)<15-20High Anion Gap (Uremic) Metabolic AcidosisRetention of unmeasured anions: sulfate, phosphate, urate, hippurate, oxalate
As Harrison's 22E states directly:
"The hyperchloremic acidosis of moderate CKD (stage 3B) is eventually converted to the high-AG acidosis of advanced renal failure (stages 4 and 5 CKD)."

Pathogenesis

1. Reduced NH4+ (Ammonium) Production and Excretion
  • This is the primary defect in CKD
  • As nephron mass decreases, the remaining nephrons cannot synthesize sufficient NH3 (ammonia) in the proximal tubule
  • NH4+ is the major vehicle for urinary acid excretion - when it fails, H+ accumulates
  • In advanced CKD, the rate of NH4+ production and excretion is markedly reduced
2. Accumulation of Unmeasured Anions (Advanced CKD)
  • As GFR falls to <20 mL/min, filtered organic anions are poorly excreted
  • Sulfate, phosphate, urate, hippurate, hydroxypropionate, furanpropionate, and oxalate accumulate
  • These raise the anion gap: AG = Na+ - (Cl- + HCO3-)
3. Bone Buffering
  • Despite retaining up to 20 mmol/day of acid, serum HCO3- often stabilizes (typically 12-20 mEq/L) because bone carbonate salts act as buffers
  • The trade-off: progressive renal osteodystrophy (loss of bone calcium carbonate), worsening osteomalacia and osteoporosis

Serum Bicarbonate Level

  • Typically falls to 12-20 mEq/L in moderate-to-advanced CKD
  • Does NOT typically fall below 12 mEq/L unless there is a superimposed acute acidosis - bone buffers prevent this
  • Target for therapy: maintain HCO3- > 22-24 mmol/L

Respiratory Compensation

  • Secondary hyperventilation (Kussmaul breathing in severe cases)
  • Expected compensation: PCO2 = 1.5 × [HCO3-] + 8 ± 2 (Winter's formula)
  • e.g., if HCO3- = 16, expected PCO2 ≈ 32 mmHg

Consequences of Chronic Metabolic Acidosis in CKD

These are clinically important and independent reasons to treat:
  1. Muscle catabolism and wasting - acid activates the ubiquitin-proteasome pathway
  2. Bone disease - bone carbonate depletion worsens renal osteodystrophy
  3. CKD progression - high-AG acidosis in advanced CKD independently accelerates the progressive loss of kidney function
  4. Hyperkalemia - acidosis shifts K+ out of cells
  5. Hormonal effects - reduces growth hormone and IGF-1 signaling

Treatment

  • Oral alkali supplementation (1.0-1.5 mmol/kg/day) to maintain serum HCO3- >22-24 mmol/L
    • Sodium bicarbonate tablets (650 mg = 7.8 mEq) or sodium citrate (Shohl's solution)
  • Dietary modification: increasing fruits and vegetables (citrate-rich) raises plasma HCO3- and slows CKD progression safely - hyperkalemia is not a common complication of this approach
  • Alkali therapy has been shown to slow the progression of CKD

Summary Table

ParameterFinding in CKD
Primary disturbanceMetabolic acidosis
Anion gap (early, stage 3)Normal (hyperchloremic)
Anion gap (late, stage 4-5)High (uremic, >12 mEq/L)
Serum HCO3-Typically 12-20 mEq/L
Serum Cl- (early)Elevated (reciprocal to HCO3-)
NH4+ excretionReduced
Respiratory responseCompensatory hyperventilation (low PCO2)
Urine pHVariable (not reliably acidic due to low NH4+)
Sources: Harrison's Principles of Internal Medicine 22E (2025), p. 415; Goldman-Cecil Medicine, p. 1225; Comprehensive Clinical Nephrology, 7th Ed.
Recent evidence note: Two 2024 reviews (PMID 38279993 and 39514096) highlight that metabolic acidosis in CKD is not merely a consequence but may actively drive further kidney injury - reinforcing aggressive alkali therapy targets consistent with the above textbook guidance.
This is a shared conversation. Sign in to Orris to start your own chat.